Anesthetic Management of Rare Diseases: Insights from Four Compelling Case Reports
Published: 2024-02-17
Page: 10-17
Issue: 2024 - Volume 7 [Issue 1]
Moncef Choubhi *
Department of Anesthesiology and Intensive Care, Mohammed V Military Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Mohamed Alioui
Department of Anesthesiology and Intensive Care, Mohammed V Military Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Yousra Ouhammou
Department of Scientific Research, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Wiam El Jellouli
Department of Scientific Research, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Taoufik Kachani
Department of Anesthesiology and Intensive Care, Mohammed V Military Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Houda Nadir
Department of Scientific Research, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Khalil Abou Elalaa
Department of Anesthesiology and Intensive Care, Mohammed V Military Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Background: Rare diseases, with a prevalence of 4% globally, often manifest with diverse and challenging clinical presentations. Anesthetic management for these conditions demands a nuanced understanding of pathophysiology, potential complications, and interactions with anesthetic agents. This study aims to shed light on the anesthetic challenges posed by rare diseases through a detailed analysis of four cases. By exploring the complexities encountered in Hurler's disease, Rubinstein-Taybi syndrome, Churg-Strauss Syndrome, and Xeroderma Pigmentosum, we seek to contribute valuable insights into the adaptability required in anesthetic approaches for these unique patient populations.
Discussion: Through the exploration of four distinct cases, we have unraveled the intricacies surrounding anesthetic management in rare diseases. Each case highlighted the imperative need for adaptability, meticulous planning, and collaboration across medical disciplines to ensure favorable perioperative outcomes.
The success in managing Hurler's disease underscored the significance of tailored plans integrating enzyme replacement therapy and detailed preoperative assessments. Similarly, addressing difficult airway challenges in Rubinstein-Taybi syndrome showcased the adaptability essential in unique anatomical scenarios. Careful consideration of Churg-Strauss Syndrome's complexities emphasized the avoidance of specific agents and meticulous monitoring. The case of Xeroderma Pigmentosum highlighted the importance of adaptability, shifting from insufficient spinal anesthesia to general anesthesia promptly.
Conclusion: These observations stress the critical role of a patient-centric approach, multidisciplinary collaboration, and adaptability in navigating the diverse challenges presented by rare diseases. In conclusion, this study offers valuable insights into refining anesthetic strategies, ensuring personalized and safe care for patients with rare diseases.
Keywords: Anesthetic challenges, rare diseases, perioperative care, case reports